J.J. Soto Castillo

696 total citations
14 papers, 103 citations indexed

About

J.J. Soto Castillo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, J.J. Soto Castillo has authored 14 papers receiving a total of 103 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Molecular Biology. Recurrent topics in J.J. Soto Castillo's work include Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (2 papers) and CAR-T cell therapy research (2 papers). J.J. Soto Castillo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Renal cell carcinoma treatment (2 papers) and CAR-T cell therapy research (2 papers). J.J. Soto Castillo collaborates with scholars based in Spain, France and United States. J.J. Soto Castillo's co-authors include Javier Pozas, María San Román, Javier Molina‐Cerrillo, Teresa Alonso‐Gordoa, Javier Torres-Jiménez, Alfredo Carrato, Jesus Loarce‐Martos, Daniel Vilarim Araújo, Marc Oliva and Bruno Uchoa and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

J.J. Soto Castillo

11 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Soto Castillo Spain 4 50 38 27 12 11 14 103
Kayleen Bailey United States 5 79 1.6× 29 0.8× 31 1.1× 9 0.8× 8 0.7× 10 136
Bianca J. Lee United States 4 60 1.2× 53 1.4× 33 1.2× 8 0.7× 10 0.9× 9 99
Adelyn Wise United Kingdom 4 90 1.8× 71 1.9× 18 0.7× 16 1.3× 8 0.7× 5 112
Eric Bernstein United States 5 24 0.5× 30 0.8× 36 1.3× 9 0.8× 9 0.8× 8 82
Danielle Croucher Canada 6 45 0.9× 49 1.3× 10 0.4× 12 1.0× 19 1.7× 15 100
Brad Somer United States 4 47 0.9× 49 1.3× 38 1.4× 7 0.6× 12 1.1× 4 99
Leonardo Forero United States 4 47 0.9× 66 1.7× 39 1.4× 15 1.3× 9 0.8× 7 113
Anand Rajarethinam United States 5 54 1.1× 51 1.3× 46 1.7× 9 0.8× 32 2.9× 8 110
Shaobu Weng United States 2 47 0.9× 67 1.8× 12 0.4× 24 2.0× 21 1.9× 2 97
S. Lindsey Davis United States 5 41 0.8× 45 1.2× 15 0.6× 12 1.0× 13 1.2× 8 95

Countries citing papers authored by J.J. Soto Castillo

Since Specialization
Citations

This map shows the geographic impact of J.J. Soto Castillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Soto Castillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Soto Castillo more than expected).

Fields of papers citing papers by J.J. Soto Castillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Soto Castillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Soto Castillo. The network helps show where J.J. Soto Castillo may publish in the future.

Co-authorship network of co-authors of J.J. Soto Castillo

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Soto Castillo. A scholar is included among the top collaborators of J.J. Soto Castillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Soto Castillo. J.J. Soto Castillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
McCarthy, Elizabeth, Amy L. Chadwick, J.J. Soto Castillo, et al.. (2025). A multi-centre review of the use of adjuvant pembrolizumab for renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 484–484.
2.
3.
Castillo, J.J. Soto, Rafael Moreno, Carles Codony, et al.. (2023). SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy. International Journal of Molecular Sciences. 24(13). 11143–11143. 4 indexed citations
4.
López‐Tarruella, Sara, Agostina Stradella, Silvia Antolín, et al.. (2023). 406P Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC. Annals of Oncology. 34. S353–S353. 2 indexed citations
5.
Calvo, Mariona, Konstantin Penkov, Alexander I. Spira, et al.. (2023). A multi-center, open-label, randomized dose expansion study of PF-06821497, a potent and selective inhibitor of enhancer of zeste homolog 2 (EZH2), in patients with metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 41(6_suppl). TPS282–TPS282. 3 indexed citations
6.
Castillo, J.J. Soto, Agostina Stradella, Rafael Villanueva-Vázquez, et al.. (2023). Clinical outcomes in phase 1 clinical trials (Ph1-CT) when treating patients (pts) with novel immunotherapy (IT) agents at early lines for advanced disease.. Journal of Clinical Oncology. 41(16_suppl). 2586–2586. 1 indexed citations
7.
Fernández‐Guarino, M., et al.. (2022). Pure Bullous Pyoderma Gangrenosum, a Challenging Clinico-Pathological Diagnosis. Indian Journal of Dermatology. 67(4). 409–414. 1 indexed citations
8.
Araújo, Daniel Vilarim, et al.. (2022). When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents. Targeted Oncology. 17(3). 253–270. 8 indexed citations
9.
Eigentler, Thomas, Sebastian Ochsenreither, Erika Richtig, et al.. (2022). 786 Intratumorally administered CV8102 in patients with advanced solid tumors: preliminary results from ongoing expansion part in study 008. Regular and Young Investigator Award Abstracts. A818–A818. 1 indexed citations
10.
Torres-Jiménez, Javier, et al.. (2021). 6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway. Journal of Thoracic Oncology. 16(4). S701–S701.
11.
Castillo, J.J. Soto, Javier Pozas, María San Román, et al.. (2020). Tyrosine Kinase Receptors in Oncology. International Journal of Molecular Sciences. 21(22). 8529–8529. 73 indexed citations
12.
13.
Castillo, J.J. Soto, et al.. (2020). Large vessel vasculitis secondary to granulocyte-colony stimulating factor. VASA. 49(6). 509–513. 8 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kayleen Bailey Breakdown of academic impact, for papers by Bianca J. Lee Breakdown of academic impact, for papers by Adelyn Wise Breakdown of academic impact, for papers by Eric Bernstein Breakdown of academic impact, for papers by Danielle Croucher Breakdown of academic impact, for papers by Brad Somer Breakdown of academic impact, for papers by Leonardo Forero Breakdown of academic impact, for papers by Anand Rajarethinam Breakdown of academic impact, for papers by Shaobu Weng Breakdown of academic impact, for papers by S. Lindsey Davis
Rankless by CCL
2026